Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 4:10 pm Purchase | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 3,018,707 9.99% | 706,080![]() (+30.53%) | View |
2022-02-11 4:19 pm Sale | 13G | Beyond Air, Inc. XAIR | Flynn James E | 833,334 3.03% | -23,529![]() (-2.75%) | View |
2022-02-08 5:35 pm Purchase | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 2,312,627 7.76% | 333,062![]() (+16.83%) | View |
2021-05-04 4:38 pm Purchase | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 1,979,565 9.6% | 564,169![]() (+39.86%) | View |
2021-02-12 2:51 pm Sale | 13G | Beyond Air, Inc. XAIR | Allianz Global Investors U.S. Holdings LLC | 0 0% | -889,154![]() (Position Closed) | View |
2020-03-13 4:44 pm Purchase | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 1,415,396 9.8% | 1,415,396![]() (New Position) | View |
2020-01-23 10:51 am Unchanged | 13G | Beyond Air, Inc. XAIR | Flynn James E | 856,863 5.78% | 0 (Unchanged) | View |
2019-02-13 12:07 pm Purchase | 13G | AIT Therapeutics Inc. AITB | Allianz Global Investors U.S. Holdings LLC | 889,154 9.985% | 143,810![]() (+19.29%) | View |
2019-02-12 4:13 pm Sale | 13G | AIT Therapeutics Inc. AITB | Flynn James E | 856,863 9.12% | -325,009![]() (-27.50%) | View |
2018-04-02 12:54 pm Sale | 13G | AIT Therapeutics Inc. AITB | KINGDON CAPITAL MANAGEMENT L.L.C. | 400,859 4.77% | -99,142![]() (-19.83%) | View |